Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-001413-24Phase 2Completed
Phase 2, randomised, double-blind trial in postoperative pain comparing TAP block with ropivacaine with TAP block with placebo (2 arms). Primary endpoint: Morphine consumption in first 24 postoperative hours. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-001413-24.